Clinical trialNCT04385303CompletedPhase 3Interventional

Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)

SponsorBiosplice Therapeutics, Inc.Enrollment496Knee Osteoarthritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Yusuf Yazici, M.D.
Biosplice Therapeutics, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Birmingham, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Canoga Park, California, United States
Research Site
Garden Grove, California, United States
Research Site
La Mesa, California, United States
Research Site
Norco, California, United States
Research Site
Pomona, California, United States
Research Site
San Diego, California, United States
Research Site
Santa Monica, California, United States
Research Site
Thousand Oaks, California, United States
Research Site
Westminster, California, United States
Research Site
Boulder, Colorado, United States
Research Site
Hamden, Connecticut, United States
Reserach Site
Clearwater, Florida, United States
Research Site
Edgewater, Florida, United States
Research Site
Gulf Breeze, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Miami Lakes, Florida, United States
Research Site
Sunrise, Florida, United States
Research Site
Sweetwater, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Winter Haven, Florida, United States
Research Site 1
Winter Park, Florida, United States
Research Site
Marietta, Georgia, United States
Research Site
Newnan, Georgia, United States
Research Site
Woodstock, Georgia, United States
Research Site
Boise, Idaho, United States
Research Site
Chicago, Illinois, United States
Research Site
Gurnee, Illinois, United States
Research Site
Oak Brook, Illinois, United States
Research Site
Evansville, Indiana, United States
Research Site
Greenwood, Indiana, United States

36 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 May 2020
Primary completion: 8 Sept 2021
Completion: 8 Sept 2021
Last update posted: 4 Feb 2026
Registered enrollment: 496
Registry id: NCT04385303

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.